Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 361, Issue 1, 2000, Pages 19-24

  Nakazi, M ^a   Bauer, U ^a   Nickel, T ^a   Kathmann, M ^a   Schlicker, E ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

5 Hydroxytryptamine (5 HT) release; 35S GTP S binding; 3H WIN 55,212 2 binding; Acetylcholine release; Cannabinoid CB1 receptor; Mouse brain cortex; Presynaptic receptors; Serotoninergic neurones

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CALCIUM ION; CANNABINOID RECEPTOR; CHOLINE; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); HISTAMINE; HISTAMINE RECEPTOR; INDALPINE; METITEPINE; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR; POTASSIUM ION; PRESYNAPTIC RECEPTOR; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; RECEPTOR SUBTYPE; RIMONABANT; SEROTONIN; TETRODOTOXIN; TRITIUM;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN ELECTROPHYSIOLOGY; CONCENTRATION RESPONSE; CONTROLLED STUDY; HORMONE RECEPTOR INTERACTION; MALE; METABOLIC INHIBITION; MOUSE; NONHUMAN; RECEPTOR BINDING; REGULATORY MECHANISM; SEROTONIN RELEASE;

ANIMALS; BRAIN CHEMISTRY; CALCIUM CHANNEL BLOCKERS; CEREBRAL CORTEX; ELECTRIC STIMULATION; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); MALE; MEMBRANES; MICE; MORPHOLINES; NAPHTHALENES; POTASSIUM; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; RECEPTORS, PRESYNAPTIC; SEROTONIN; SEROTONIN ANTAGONISTS;

EID: 0033967787     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002109900147     Document Type: Article

References (27)

1. ( Ameri A (1999) The effects of cannabinoids on the brain. Prog Neurobiol 58:315-348
2. Ameri A, Wilhelm A, Simmet A (1999) Effects of the endogenous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices. Br J Pharmacol 126:1831-1839
3. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
4. Cadogan AK, Alexander SPH, Boyd EA, Kendall DA (1997) Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum. J Neurochem 69:1131-1137
5. Childers SR, Breivogel CS (1998) Cannabis and endogenous cannabinoid systems. Drug Alcohol Depend 51:173-187
6. Coutts AA, Pertwee RG (1997) Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus. Br J Pharmacol 121:1557-1566
7. 1 receptors in human ileum. Br J Pharmacol 125:1393-1395
8. Furchgott RF (1972) The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Blaschko H, Muscholl E (eds) Handbook of experimental pharmacology, vol 33. Springer, Berlin Heidelberg New York, pp 283-335
9. Gardner EL, Vorel SR (1998) Cannabinoid transmission and reward-related events. Neurobiol Disease 5:502-533
10. Gessa GL, Mascia MS, Casu MA, Carta G (1997) Inhibition of hippocampal acetylcholine release by cannabinoids: reversal by SR 141716A. Eur J Pharmacol 327:R1-R2
11. Gifford AN, Ashby CR (1996) Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR 141716 A. J Pharmacol Exp Ther 277:1431-1436
12. 9-tetrahydro-cannabinol on neurotransmitter accumulation and release mechanisms in rat forebrain synaptosomes. Life Sci 19:347-356
13. 1 receptor-mediated inhibition of NMDA-and kainate-stimulated noradrenaline and dopamine release in the brain. Naunyn-Schmiedeberg's Arch Pharmacol 359:466-470
14. 1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurones. J Neurosci 19:4544-4558
15. Lévénès C, Daniel H, Soubrié P, Crépel F (1998) Cannabinoids decrease excitatory synaptic transmission and impair long-term depression in rat cerebellum. J Physiol (London) 510:867-879
16. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561-564
17. 2 receptors. Pharmacol Ther 74:129-180
18. 2. Naunyn-Schmiedeberg's Arch Pharmacol 335:646-651
19. 3 receptor-mediated inhibition of serotonin release in the rat brain cortex. Naunyn-Schmiedeberg's Arch Pharmacol 337:588-590
20. Schlicker E, Glaser T, Lümmen G, Neise A, Göthert M (1991a) Serotonin and histamine receptor-mediated inhibition of serotonin and noradrenaline release in rat brain cortex under nimodipine treatment. Neurochem Int 19:437-444
21. 1-24, angiotensin II, bradykinin and delta-sleep-inducing peptide. Naunyn-Schmiedeberg's Arch Pharmacol 343:117-122
22. Schlicker E, Timm J, Göthert M (1996) Cannabinoid receptor-mediated inhibition of dopamine release in the retina. Naunyn-Schmiedeberg's Arch Pharmacol 354:791-795
23. 1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus. Naunyn-Schmiedeberg's Arch Pharmacol 356:583-589
24. 35S]thio)triphosphate binding in rat brain membranes. Life Sci 59:659-668
25. Shen M, Piser TM, Seybold VS, Thayer SA (1996) Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J Neurosci 16:4322-4334
26. Stefano GB, Salzet B, Rialas CM, Pope M, Kustka A, Neenan K, Pryor S, Salzet M (1997) Morphine-and anandamide-stimulated nitric oxide production inhibits presynaptic dopamine release. Brain Res 763:63-68
27. Szabo B, Dörner L, Pfreundtner C, Nörenberg W, Starke K (1998) Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum. Neuroscience 85:395-403